表观遗传年龄加速与头颈癌患者危险因素、生存及生活质量的相关性
本研究纳入无远处转移的头颈癌放疗患者,在放疗前、放疗结束时及放疗后6、12个月计算表观遗传年龄加速(EAA),分析其危险因素及与总生存(OS)、无进展生存(PFS)和生活质量(QOL)的关联。结果显示合并症多、非HPV相关症状及治疗相关症状重与EAA升高相关,BMI与EAA呈非线性关联;EAA升高与更差的OS、PFS及QOL相关。
要点
- 合并症多、非HPV相关症状及治疗相关症状重与EAA升高相关。
- BMI与EAA呈非线性关联,BMI<35 kg/m2降低或≥35 kg/m2升高均与更高EAA相关。
- EAA每增加1年与更差OS、PFS及QOL相关。
核心结论
- 临床特征比人口学及生活方式因素更可能促进头颈癌患者生物学衰老加速。
- 表观遗传年龄加速与更差的OS、PFS及QOL相关,EAA可作为癌症结局标志物。
研究设计与样本
- 纳入无远处转移的头颈癌放疗患者,在放疗前、放疗结束时及放疗后6、12个月共4个时间点计算EAA。
- EAA采用DNAmPhenoAge计算,生存数据收集至2020年8月,QOL采用FACT-HNC量表评估。
临床怎么用
- 可将EAA作为头颈癌放疗患者癌症结局的标志物进行考量。
- 减缓衰老可能改善头颈癌患者的生存和生活质量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Epigenetic age acceleration (EAA) is robustly linked with mortality and morbidity. This study examined risk factors of EAA and its association with overall survival (OS), progression-free survival (PFS), and quality of life (QOL) in patients with head and neck cancer (HNC) receiving radiation therapy. METHODS AND MATERIALS: Patients without distant metastasis were enrolled and followed before and at the end of radiation therapy and at 6 and 12 months after radiation therapy. EAA was calculated with DNAmPhenoAge at all 4 time points. Risk factors included demographic characteristics, lifestyle, clinical characteristics, treatment-related symptoms, and blood biomarkers. Survival data were collected until August 2020, and QOL was measured using Functional Assessment of Cancer Therapy-HNC. RESULTS: Increased comorbidity, symptoms unrelated to human papilloma virus, and more severe treatment-related symptoms were associated with higher EAA (P = .03 to P < .001). A nonlinear association (quadratic) between body mass index (BMI) and EAA was observed: decreased BMI (<35 kg/m2; P = .04) and increased BMI (≥35 kg/m2; P = .01) were linked to higher EAA. Increased EAA (per year) was associated with worse OS (hazard ratio [HR], 1.11 [95% confidence interval {CI}, 1.03-1.18; P = .004]; HR, 1.10 [95% CI, 1.01-1.19; P = .02] for EAA at 6 and 12 months after treatment, respectively) and PFS (HR, 1.10 [95% CI, 1.02-1.19; P = .02]; HR, 1.14 [95% CI, 1.06-1.23; P < .001]; and HR, 1.08 [95% CI, 1.02-1.14; P = .01]) for EAA before, immediately after, and 6 months after radiation therapy, respectively) and QOL over time (β = -0.61; P = .001). An average of 3.25 to 3.33 years of age acceleration across time, which was responsible for 33% to 44% higher HRs of OS and PFS, was observed in those who died or developed recurrence compared with those who did not (all P < .001). CONCLUSIONS: Compared with demographic and lifestyle factors, clinical characteristics were more likely to contribute to faster biological aging in patients with HNC. Acceleration in epigenetic age resulted in more aggressive adverse events, including OS and PFS. EAA could be considered as a marker for cancer outcomes, and decelerating aging could improve survival and QOL.
引用
- Xiao C, Miller AH, Peng G, et al. Association of Epigenetic Age Acceleration With Risk Factors, Survival, and Quality of Life in Patients With Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2021. PMID: 33882281. doi:10.1016/j.ijrobp.2021.04.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。